{"id":"W4399452280","doi":"10.1200/jco.2024.42.17_suppl.lba8503","title":"Lorlatinib vs crizotinib in treatment-naïve patients with advanced <i>ALK</i>+ non-small cell lung cancer: 5-year progression-free survival and safety from the CROWN study.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Crizotinib; Medicine; Lung cancer; Oncology; Internal medicine; Progression-free survival; Overall survival; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001582757,0.0005518424,0.001326795,0.0002469777,0.0001882618,0.0006263294,0.0005653379,0.0006276545,0.001875044],"category_scores_gemma":[0.001752059,0.0002394256,0.001344789,0.0002858546,0.0005228838,0.0004103092,0.0003419717,0.00127495,0.0002566746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001362068,"about_ca_system_score_gemma":0.001085986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003136265,"about_ca_topic_score_gemma":0.01155633,"domain_scores_codex":[0.999355,0.0003529494,0.00004449378,0.00008046677,0.00009319241,0.00007398792],"domain_scores_gemma":[0.9987881,0.0003269962,0.000385848,0.00008668355,0.00006921231,0.0003432543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9144819,0.002320191,0.01878382,0.0007180907,0.002799854,0.0001169778,0.0001762039,0.001327087,0.00631362,0.0001532901,0.00233771,0.05047118],"study_design_scores_gemma":[0.557952,0.2878893,0.1346676,0.000139147,0.00501813,0.0005511989,0.0001743042,0.003489891,0.002651146,0.0003741397,0.007016499,0.00007665937],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923226,0.005391905,0.00008802504,0.0002633236,0.00005838249,0.0002230204,0.0004901089,0.00001820514,0.001144414],"genre_scores_gemma":[0.9965414,0.00127824,0.0002285914,0.0003125627,0.0001122338,0.0001328262,0.0008416087,0.000005089123,0.0005473181],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003136265,"threshold_uncertainty_score":0.009882569,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03311750923203254,"score_gpt":0.4386722818950109,"score_spread":0.4055547726629783,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}